[The relationship between genotype of familial hypercholesterolemia and the efficacy of PCSK9 inhibitors].

Abstract excerpt

Objective: This study intends to explore the difference in the efficacy of PCSK9 inhibitors in patients with different FH phenotypes by analyzing the level of blood lipids before and after treatment with PCSK9 inhibitors in patients with familial hypercholesterolemia (FH) with different allele grades. Methods: Patients with FH phenotype, who admitted to Beijing Anzhen Hospital from January 2019 to October 2020,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Genotype
• Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors